πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

10,225 results for β€œHe” Clear

  1. Topiramate

    United Therapeutics Europe Ltd

    PTSD

    approved small molecule completed

    1 trial

  2. Topiramate

    United Therapeutics Europe Ltd

    Alcohol Dependence

    approved small molecule completed

    1 trial

  3. Topiramate

    United Therapeutics Europe Ltd

    Traumatic Brain Injury (TBI)

    approved small molecule completed

    1 trial

  4. Toripalimab

    Coherus Oncology

    Nasopharyngeal Cancer Recurrent

    approved small molecule active

    1 trial

  5. Tramadol HCI/acetaminophen

    Janssen-Cilag Pty Ltd

    Cancer

    approved small molecule completed

    1 trial

  6. Tranexamic Acid

    The First People's Hospital of Lianyungang

    Postpartum Hemorrhage， Cesarean Section

    approved small molecule active

    1 trial

  7. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial

  8. Trangorex 200 mg comprimidos

    The George Institute

    Atrial fibrillation

    approved small molecule active

    1 trial

  9. Transanal irrigation with Peristeen Anal Irrigation

    Stoke Therapeutics

    Constipation

    approved other completed

    1 trial

  10. Trastuzumab Rezetecan

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  11. Trazodone

    United Therapeutics Europe Ltd

    Sleep Apnea

    approved small molecule active

    1 trial

  12. Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    3 trials

  13. Triamcinolone acetonide-Ketorolac-Ropivacaine

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved small molecule active

    1 trial

  14. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  15. Trimetazidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

  16. Triple antithrombotic therapy

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome (ACS)

    approved small molecule active

    1 trial

  17. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  18. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  19. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  20. Typhoid Vi vaccine

    International Peace Maternity and Child Health Hospital

    Typhoid

    approved mab completed

    1 trial

  21. Ublituximab

    TG THERAPEUTICS, INC.

    Multiple Sclerosis

    approved mab active

    4 trials

  22. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    Disc Medicine

    Paroxysmal nocturnal hemoglobinuria (PNH)

    approved small molecule active

    1 trial

  23. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    The George Institute

    IgA nephropathy

    approved small molecule active

    1 trial

  24. Urapidil Accord 5 mg/ml soluciΓ³n inyectable y para perfusiΓ³n EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml soluciΓ³n inyectable y para perfusiΓ³n.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources